View More Recent Stories

Sep 26, 2024 08:00AM PTC Therapeutics (PTCT): FDA Grants Fast Track Designation to PTC518 Huntington's Disease Program
Sep 5, 2024 01:58PM TD Cowen Reiterates Hold Rating on PTC Therapeutics (PTCT)
Sep 4, 2024 06:29AM Baird Starts PTC Therapeutics (PTCT) at Outperform
Aug 26, 2024 02:57PM PTC Therapeutics (PTCT) ATM March 34 calls active
Aug 9, 2024 02:10PM PTC Therapeutics (PTCT) PT Raised to $33 at TD Cowen
Jul 30, 2024 08:01AM PTC Therapeutics (PTCT) Submits Sepiapterin NDA Submission to FDA
Jun 28, 2024 06:00AM PTC Therapeutics (PTCT) Receives Negative CHMP Opinion on Translarna
Jun 21, 2024 05:37AM PTC Therapeutics (PTCT) PT Raised to $32 at BofA Securities
Jun 21, 2024 05:27AM Goldman Sachs Reiterates Sell Rating on PTC Therapeutics (PTCT)
Jun 20, 2024 01:12PM JPMorgan on PTC Therapeutics (PTCT): 'Despite Notable Unknowns for Clinical & Regulatory Outlook, 12-mo PIVOT-HD Update Solidly Encouraging on All Fronts'
Jun 20, 2024 01:03PM Citi Reiterates Sell Rating on PTC Therapeutics (PTCT), 'PIVOT-HD Data Update Supportive, But Expectations Measured to this Point'
Jun 20, 2024 06:31AM PTC Therapeutics (PTCT) Reports Interim PIVOT-HD Results Demonstrate Evidence of Favorable CNS Biomarker and Clinical Effects
View More Recent Stories